M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
Public ClinicalTrials.gov record NCT01621243. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II, Two-Part, Multicenter Study to Evaluate the Safety and Efficacy of M402 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer
Study identification
- NCT ID
- NCT01621243
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Momenta Pharmaceuticals, Inc.
- Industry
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Interventions
- Necuparanib Drug
- gemcitabine Drug
- nab-paclitaxel Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2012
- Primary completion
- Oct 23, 2016
- Completion
- Oct 23, 2016
- Last update posted
- Aug 28, 2018
2012 – 2016
United States locations
- U.S. sites
- 34
- U.S. states
- 21
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Clearview Cancer Institute | Huntsville | Alabama | 35805 | — |
| Arizona Clinical Research Center | Tucson | Arizona | 85715 | — |
| University of Arizona | Tucson | Arizona | 85719 | — |
| University of Colorado School of Medicine - Division of Medical Oncology | Aurora | Colorado | 80045 | — |
| Poudre Valley Health System | Fort Collins | Colorado | 80528 | — |
| Hartford Healthcare Cancer Institute at Midstate Medical Center | Meriden | Connecticut | 06451 | — |
| Florida Hospital Tampa | Tampa | Florida | 33613 | — |
| Southeastern Regional Medical Center | Newnan | Georgia | 30265 | — |
| Illinois Cancer Specialists | Arlington Heights | Illinois | 60005 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Crescent City Research Consortium | Marrero | Louisiana | 70072 | — |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | — |
| University of Maryland- St Joseph's Medical Center | Towson | Maryland | 21204 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Umass Memorial Medical Center | Worcester | Massachusetts | 01605 | — |
| St. Joseph Mercy Hospital | Ann Arbor | Michigan | 48105 | — |
| Karmanos Cancer Center | Detroit | Michigan | 48201 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Metro-Minnesota Community Clinical Oncology Program | Saint Louis Park | Minnesota | 55416 | — |
| University of Kansas Cancer Center | Kansas City | Missouri | 64154 | — |
| University of New Mexico Cancer Center | Albuquerque | New Mexico | 87131 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Montefiore-Einstein Center for Cancer Care | The Bronx | New York | 10461 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Northwest Cancer Specialists | Portland | Oregon | 97227 | — |
| Penn State Hershey Cancer Center | Hershey | Pennsylvania | 17033 | — |
| Cancer Center of the Carolinas/ITOR | Greenville | South Carolina | 29605 | — |
| University of Texas Health Sciences Center | San Antonio | Texas | 78229 | — |
| Texas Oncology, P.A. | Tyler | Texas | 75702 | — |
| Texas Oncology | Tyler | Texas | 75702 | — |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01621243, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2018 · Synced Apr 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01621243 live on ClinicalTrials.gov.